The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy
Open accessAbstract
Exosomes derived from mesenchymal stem cells (MSCs) have been evaluated for their potential to be used as drug delivery vehicles. Synthetically personalized exosome mimetics (EMs) could be the alternative vesicles for drug delivery. In this study, we aimed to isolate EMs from human MSCs. Cells were mixed with paclitaxel (PTX) and PTX-loaded EMs (PTX-MSC-EMs) were isolated and evaluated for their anticancer effects against breast cancer. EMs were isolated from human bone marrow-derived MSCs. MSCs (4 106 cells/mL) were mixed with or without PTX at different concentrations in phosphate-buffered saline (PBS) and serially extruded through 10-, 5-, and 1-µm polycarbonate membrane filters using a mini-extruder. MSCs were centrifuged to remove debris and the supernatant was filtered through a 0.22-µm filter, followed by ultracentrifugation to isolate EMs and drug-loaded EMs. EMs without encapsulated drug (MSC-EMs) and those with encapsulated PTX (PTX-MSC-EMs) were characterized by western blotting, nanoparticle tracking analysis (NTA), and transmission electron microscopy (TEM). The anticancer effects of MSC-EMs and PTX-MSC-EMs were assessed with breast cancer (MDA-MB-231) cells both in vitro and in vivo using optical imaging. EMs were isolated by the extrusion method and ultracentrifugation. The isolated vesicles were positive for membrane markers (ALIX and CD63) and negative for golgi (GM130) and endoplasmic (calnexin) marker proteins. NTA revealed the size of MSC-EM to be around 145 nm, while TEM confirmed its morphology. PTX-MSC-EMs significantly (p < 0.05) decreased the viability of MDA-MB-231 cells in vitro at increasing concentrations of EM. The in vivo tumor growth was significantly inhibited by PTX-MSC-EMs as compared to control and/or MSC-EMs. Thus, MSC-EMs were successfully isolated using simple procedures and drug-loaded MSC-EMs were shown to be therapeutically efficient for the treatment of breast cancer both in vitro and in vivo. MSC-EMs may be used as drug delivery vehicles for breast cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Engineering of extracellular vesicles as drug delivery vehicles
Kim, S., & Kim, H.-S. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.08.07 · Cited by 67
RetractedSkog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Wiklander, O. P. B., Nordin, J. Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mäger, I., Vader, P., Lee, Y., Sork, H., Seow, Y., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26316 · Cited by 1,730
Jang, S. C., Kim, O. Y., Yoon, C. M., Choi, D.-S., Roh, T.-Y., Park, J., Nilsson, J., Lötvall, J., Kim, Y.-K., & Gho, Y. S. (2013) · ACS Nano · doi:10.1021/nn402232g · Cited by 1,022
Pascucci, L., Coccè, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Viganò, L., Locatelli, A., Sisto, F., Doglia, S. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.042 · Cited by 846
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 746
Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.005 · Cited by 704
Kim, M. S., Haney, M. J., Zhao, Y., Yuan, D., Deygen, I., Klyachko, N. L., Kabanov, A. V., & Batrakova, E. V. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.09.011 · Cited by 663
Paclitaxel: a review of adverse toxicities and novel delivery strategies
Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B. M., & Brem, H. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.609 · Cited by 510
Delivery of chemotherapeutic drugs in tumour cell-derived microparticles
Tang, K., Zhang, Y., Zhang, H., Xu, P., Liu, J., Ma, J., Lv, M., Li, D., Katirai, F., Shen, G.-X., et al. (2012) · Nature Communications · doi:10.1038/ncomms2282 · Cited by 453
Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery
van Dommelen, S. M., Vader, P., Lakhal, S., Kooijmans, S. A. A., van Solinge, W. W., Wood, M. J. A., & Schiffelers, R. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.021 · Cited by 398
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
Qiao, L., Xu, Z., Zhao, T., Zhao, Z., Shi, M., Zhao, R. C., Ye, L., & Zhang, X. (2008) · Cell Research · doi:10.1038/cr.2008.40 · Cited by 388
Microvesicles Derived from Human Bone Marrow Mesenchymal Stem Cells Inhibit Tumor Growth
Bruno, S., Collino, F., Deregibus, M. C., Grange, C., Tetta, C., & Camussi, G. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0304 · Cited by 309
Nanotechnological carriers for cancer chemotherapy: The state of the art
Estanqueiro, M., Amaral, M. H., Conceição, J., & Sousa Lobo, J. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.12.041 · Cited by 298
Lakhal, S., & Wood, M. J. A. (2011) · BioEssays · doi:10.1002/bies.201100076 · Cited by 271
Cousin, B., Ravet, E., Poglio, S., De Toni, F., Bertuzzi, M., Lulka, H., Touil, I., André, M., Grolleau, J.-L., Péron, J.-M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006278 · Cited by 255
The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions
Gornstein, E., & Schwarz, T. L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.016 · Cited by 252
Large-scale generation of cell-derived nanovesicles
Jo, W., Kim, J., Yoon, J., Jeong, D., Cho, S., Jeong, H., Yoon, Y. J., Kim, S. C., Gho, Y. S., & Park, J. (2014) · Nanoscale · doi:10.1039/c4nr02391a · Cited by 232
Carbon nanotubes from synthesis to in vivo biomedical applications
Sajid, M. I., Jamshaid, U., Jamshaid, T., Zafar, N., Fessi, H., & Elaissari, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.064 · Cited by 230
RNAi delivery by exosome-mimetic nanovesicles – Implications for targeting c-Myc in cancer
Lunavat, T. R., Jang, S. C., Nilsson, L., Park, H. T., Repiska, G., Lässer, C., Nilsson, J. A., Gho, Y. S., & Lötvall, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.024 · Cited by 225
Gangadaran, P., Rajendran, R. L., Lee, H. W., Kalimuthu, S., Hong, C. M., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.022 · Cited by 210
Self-citationRajendran, R. L., Gangadaran, P., Bak, S. S., Oh, J. M., Kalimuthu, S., Lee, H. W., Baek, S. H., Zhu, L., Sung, Y. K., Jeong, S. Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15505-3 · Cited by 187
Self-citationMesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy
Pessina, A., Bonomi, A., Coccè, V., Invernici, G., Navone, S., Cavicchini, L., Sisto, F., Ferrari, M., Viganò, L., Locatelli, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028321 · Cited by 167
Applications of Nanoparticles for Anticancer Drug Delivery: A Review
Zhu, Y., & Liao, L. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2015.10298 · Cited by 157
An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles
Gangadaran, P., Hong, C. M., & Ahn, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00169 · Cited by 146
Self-citationNeurological adverse effects caused by cytotoxic and targeted therapies
Schiff, D., Wen, P. Y., & van den Bent, M. J. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.128 · Cited by 129
Gangadaran, P., Li, X. J., Lee, H., Oh, J. M., Kalimuthu, S., Rajendran, R. L., Son, S. H., Baek, S. H., Singh, T. D., Zhu, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22493 · Cited by 122
Self-citationSzebeni, J., & Storm, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.177 · Cited by 111
Stem cells as vectors for antitumour therapy
Loebinger, M. R., & Janes, S. M. (2010) · Thorax · doi:10.1136/thx.2009.128025 · Cited by 109
Exosomes: the ideal nanovectors for biodelivery
Fais, S., Logozzi, M., Lugini, L., Federici, C., Azzarito, T., Zarovni, N., & Chiesi, A. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0236 · Cited by 93
Kalimuthu, S., Gangadaran, P., Li, X. J., Oh, J. M., Lee, H., Jeong, S. Y., Lee, S., Lee, J., & Ahn, B. (2016) · Scientific Reports · doi:10.1038/srep30418 · Cited by 74
Self-citationZheng, H., Li, Y., Wang, Y., Zhao, H., Zhang, J., Chai, H., Tang, T., Yue, J., Guo, A. M., & Yang, J. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.07.018 · Cited by 71
Cell vehicle targeting strategies
Roth, J. C., Curiel, D. T., & Pereboeva, L. (2008) · Gene Therapy · doi:10.1038/gt.2008.38 · Cited by 71
Mesenchymal stromal cells as a drug delivery system
Menon, L. G., Shi, V. J., & Carroll, R. S. (2009) · doi:10.3824/stembook.1.35.1 · Cited by 28
Cited by
Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
Weng, Z., Zhang, B., Wu, C., Yu, F., Han, B., Li, B., & Li, L. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01141-y · Cited by 405
The emerging role of exosomes in mental disorders
Saeedi, S., Israel, S., Nagy, C., & Turecki, G. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0459-9 · Cited by 370
Artificial exosomes for translational nanomedicine
Li, Y.-J., Wu, J.-Y., Liu, J., Xu, W., Qiu, X., Huang, S., Hu, X.-B., & Xiang, D.-X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00986-2 · Cited by 303
Lin, Z., Wu, Y., Xu, Y., Li, G., Li, Z., & Liu, T. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01650-5 · Cited by 297
Shao, J., Zaro, J., & Shen, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s281890 · Cited by 295
Metadata
- Authors
- Kalimuthu, S., Gangadaran, P., Rajendran, R. L., Zhu, L., Oh, J. M., Lee, H. W., Gopal, A., Baek, S. H., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-26
- Volume
- 9
- Pages
- 1116-1116
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2891582149
- Cited by
- 268
- References
- 37
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.